Sarcoma Risk Assessment Program
Sarcomas are rare cancers found in bone or connective tissue and account for less than 5 percent of all cancers diagnosed in the United States. Recent studies have suggested that certain inherited diseases are associated with increased risk of developing a sarcoma. These include Li-Fraumeni
Syndrome, Von Recklinghausen’s Disease, and Paget’s Disease.
Pennsylvania Hospital’s Sarcoma Program is conducting genetic research on sarcomas to improve prevention and treatment. Genetic testing is a process in which the inherited genetic material, called DNA, is carefully tested for alterations. DNA is obtained from a simple blood test. Certain families may benefit from genetic testing for specific inherited conditions.
If you are likely to have an inherited cancer syndrome, the choice to pursue genetic testing is yours. Our program provides education about the benefits, limitations, and potential drawbacks of genetic testing to help you make the decision that is right for you.